Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.85% |
| 2 | Consumer Discretionary | 1.02% |
| 3 | Financials | 0.76% |
| 4 | Communication Services | 0.62% |
| 5 | Healthcare | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
PUT
Zebra Technologies
ZBRA
$17.1B
| $23M | ﹤0.01% |
62,200
+3,600
| +6% | +$1.21M |
|
|
GAP
1677
CALL
The Gap Inc
GAP
$7.25B
| $23M | ﹤0.01% |
1,044,500
-938,600
| -47% | -$20.8M |
|
1678
CALL
Inspire Medical Systems
INSP
$1.77B
| $23M | ﹤0.01% |
109,000
+54,100
| +99% | +$9.4M |
|
1679
PUT
Annaly Capital Management
NLY
$17.4B
| $23M | ﹤0.01% |
1,144,500
+98,800
| +9% | +$1.98M |
|
1680
CALL
Comfort Systems
FIX
$55B
| $23M | ﹤0.01% |
58,800
+13,300
| +29% | +$4.38M |
|
1681
CALL
Powell Industries
POWL
$6.93B
| $22.9M | ﹤0.01% |
309,600
+221,400
| +251% | +$12.1M |
|
1682
Carnival Corporation Ltd
CCL
$35.8B
| $22.9M | ﹤0.01% |
1,239,194
-333,876
| -21% | -$5.65M |
|
1683
CALL
TG Therapeutics
TGTX
$8.48B
| $22.9M | ﹤0.01% |
978,800
+338,300
| +53% | +$7.39M |
|
1684
PUT
Southern Copper
SCCO
$186B
| $22.9M | ﹤0.01% |
212,709
+24,317
| +13% | +$2.37M |
|
1685
CALL
Darling Ingredients
DAR
$9.88B
| $22.9M | ﹤0.01% |
615,400
+150,700
| +32% | +$5.68M |
|
1686
PUT
Western Alliance Bancorporation
WAL
$8.69B
| $22.9M | ﹤0.01% |
264,200
-138,700
| -34% | -$10.7M |
|
1687
CALL
BCE
BCE
$22B
| $22.8M | ﹤0.01% |
655,800
-402,100
| -38% | -$13.7M |
|
1688
CALL
Sanofi
SNY
$110B
| $22.8M | ﹤0.01% |
395,600
+165,300
| +72% | +$8.92M |
|
1689
CALL
AGNC Investment
AGNC
$12.9B
| $22.8M | ﹤0.01% |
2,178,600
-276,400
| -11% | -$2.81M |
|
1690
PUT
Core Scientific
CORZ
$5.79B
| $22.7M | ﹤0.01% |
1,916,800
+887,500
| +86% | +$9.2M |
|
1691
PUT
Ascendis Pharma A/S
ASND
$16.6B
| $22.7M | ﹤0.01% |
152,200
+65,600
| +76% | +$8.86M |
|
|
APLS
1692
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $22.7M | ﹤0.01% |
787,500
-241,300
| -23% | -$8.94M |
|
1693
CALL
MKS Inc
MKSI
$18.3B
| $22.7M | ﹤0.01% |
208,700
+84,100
| +67% | +$9.99M |
|
1694
CALL
DigitalOcean
DOCN
$13.2B
| $22.7M | ﹤0.01% |
561,300
-556,400
| -50% | -$19.8M |
|
1695
CALL
MP Materials
MP
$10.7B
| $22.7M | ﹤0.01% |
1,283,400
+730,400
| +132% | +$9.92M |
|
1696
PUT
Enovix
ENVX
$742M
| $22.6M | ﹤0.01% |
2,765,143
+969,372
| +54% | +$10.1M |
|
1697
Northrop Grumman
NOC
$77.1B
| $22.6M | ﹤0.01% |
42,727
-48,772
| -53% | -$23.9M |
|
1698
CALL
Transmedics
TMDX
$3.25B
| $22.6M | ﹤0.01% |
143,700
-5,300
| -4% | -$817K |
|
1699
CALL
Centene
CNC
$32.1B
| $22.5M | ﹤0.01% |
299,500
+22,400
| +8% | +$1.64M |
|
1700
CALL
Axsome Therapeutics
AXSM
$10.8B
| $22.5M | ﹤0.01% |
250,700
+63,900
| +34% | +$5.58M |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.